Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
13.00
-0.21 (-1.59%)
Aug 14, 2026, 9:58 AM EDT - Market open
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $148.55 million as of August 14, 2026. Its market cap has increased by 1,526.53% in one year.
Market Cap
148.55M
Enterprise Value
102.28M
1-Year Change
1,526.53%
Ranking
Category
Stock Price
$13.00
ChartMarket Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has increased from $141.44M to $148.55M, an increase of 5.03%. That is a compound annual growth rate of 0.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 146.15M | 87.12% |
| Dec 31, 2025 | 78.10M | 913.26% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 158.34M |
| Jyong Biotech | 152.92M |
| Canton Strategic Holdings | 152.70M |
| LENZ Therapeutics | 151.13M |
| Molecular Partners AG | 150.64M |
| Milestone Pharmaceuticals | 147.61M |
| Cibus | 146.56M |
| NRx Pharmaceuticals | 143.75M |